TCI GENE Past Earnings Performance
Past criteria checks 3/6
TCI GENE's earnings have been declining at an average annual rate of -27.4%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been declining at an average rate of 4.6% per year. TCI GENE's return on equity is 2.6%, and it has net margins of 7.9%.
Key information
-27.4%
Earnings growth rate
-35.1%
EPS growth rate
| Healthcare Industry Growth | 9.1% |
| Revenue growth rate | -4.6% |
| Return on equity | 2.6% |
| Net Margin | 7.9% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How TCI GENE makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 349 | 27 | 139 | 41 |
| 31 Mar 24 | 341 | 20 | 131 | 43 |
| 31 Dec 23 | 334 | 12 | 123 | 46 |
| 30 Sep 23 | 329 | 12 | 113 | 55 |
| 30 Jun 23 | 325 | 13 | 103 | 65 |
| 31 Mar 23 | 375 | 42 | 97 | 64 |
| 31 Dec 22 | 424 | 72 | 90 | 62 |
| 30 Sep 22 | 486 | 102 | 86 | 61 |
| 30 Jun 22 | 547 | 132 | 81 | 60 |
| 31 Mar 22 | 490 | 112 | 74 | 60 |
| 31 Dec 21 | 432 | 92 | 67 | 59 |
| 30 Sep 21 | 339 | 72 | 58 | 49 |
| 30 Jun 21 | 247 | 51 | 49 | 38 |
| 31 Mar 21 | 220 | 43 | 48 | 32 |
| 31 Dec 20 | 193 | 36 | 47 | 26 |
Quality Earnings: 6879 has a high level of non-cash earnings.
Growing Profit Margin: 6879's current net profit margins (7.9%) are higher than last year (3.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6879's earnings have declined by 27.4% per year over the past 5 years.
Accelerating Growth: 6879's earnings growth over the past year (114.7%) exceeds its 5-year average (-27.4% per year).
Earnings vs Industry: 6879 earnings growth over the past year (114.7%) exceeded the Healthcare industry 6.3%.
Return on Equity
High ROE: 6879's Return on Equity (2.6%) is considered low.